BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12355837)

  • 21. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
    Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
    J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
    Falcone M; Sarvetnick N
    Clin Immunol; 1999 Jan; 90(1):2-9. PubMed ID: 9884346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK
    J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
    Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
    J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmunity. A diversity of diabetes.
    Parham P
    Nature; 1990 Jun; 345(6277):662-4. PubMed ID: 1972776
    [No Abstract]   [Full Text] [Related]  

  • 27. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.
    Polanski M; Melican NS; Zhang J; Weiner HL
    J Autoimmun; 1997 Aug; 10(4):339-46. PubMed ID: 9237797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NOD mouse model of type 1 diabetes: as good as it gets?
    Atkinson MA; Leiter EH
    Nat Med; 1999 Jun; 5(6):601-4. PubMed ID: 10371488
    [No Abstract]   [Full Text] [Related]  

  • 32. Tracking autoimmune T cells in diabetes.
    Serreze DV; Leiter EH
    J Clin Invest; 2003 Sep; 112(6):826-8. PubMed ID: 12975466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H
    Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
    J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes results from a late change in the autoimmune response of NOD mice.
    Gazda LS; Charlton B; Lafferty KJ
    J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
    Götz J; Eibel H; Köhler G
    Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
    Haskins K
    J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus.
    Diabetologia; 1994 Oct; 37(10):42-3. PubMed ID: 7851688
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune cells, pancreas development, regeneration and type 1 diabetes.
    Homo-Delarche F; Drexhage HA
    Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice.
    Fox CJ; Danska JS
    J Immunol; 1997 Mar; 158(5):2414-24. PubMed ID: 9036992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.